An expert overview of left ventricular outflow tract obstruction (LVOTO)

Written in association with: Dr Antonis Pantazis
Published:
Edited by: Aoife Maguire

Left ventricular outflow tract obstruction (LVOTO) is a heart problem which takes place in the main ventricle of the heart, which can cause an array of symptoms. Renowned consultant cardiologist Dr Antonis Pantazis explains everything you need to know about the condition.

 

What is left ventricular outflow tract obstruction (LVOTO)?

The left ventricle is the main ventricle of the heart. Left ventricular outflow tract obstruction (LVOTO) is a blockage in the exit, which is the outflow tract of the left ventricle.

 

This obstruction is often caused by the combination of abnormally thickened muscle, the abnormal move of one of the valves of the left ventricle (the mitral valve) and the overall dynamic, movement of the left ventricle. This is particularly common when hypertrophic cardiomyopathy is diagnosed as an underlying condition.

 

What causes LVOTO?

There are multiple factors which can contribute to ventricular outflow tract obstruction (LVOTO) obstruction of the left ventricle.

 

Increased thickness of the muscle of the left ventricle and abnormalities of the mitral valve are common contributing factors to ventricular outflow tract obstruction. (LVOTO)

 

Another cause of LVOTO is when there is the presence of some additional muscles inside the left ventricle, which are called papillary muscles.

 

LVOTO is a multifactorial phenomenon and is very common in hypertrophic cardiomyopathy, especially on exertion, such as when the patient is undertaking any physical activity or exercising. It is less frequent at rest or when the patient is sleeping.

 

 

What are the symptoms of LVOTO?

Left ventricular outflow tract obstruction can cause breathlessness, chest pain and near fainting or fainting episodes.  This will typically happen when the patient is:

 

  • Exercising
  • Dehydrated
  • In a hot environment
  • After having a big meal
  • Has consumed alcohol

 

These are just a few of the factors which can predispose to left ventricular outflow tract obstruction.

 

LVTO is quite dynamic; it may come and ago. Patients often report having both good and bad days because this LVTO lcan occur one day, when the circumstances are more likely to cause it, but may not occur the following day.

 

Patients with LVTO often have difficulties walking up the stairs or hills and may struggle to climb.

 

Is LVOTO life-threatening?

LOVTO can provoke a lot of symptoms. It is not directly life-threatening, however, it can contribute to life-threatening risks. It is, of course, dangerous for the heart to be blocked when the it is attempting to pump blood out and is most likely related to the occurrence of arrhythmias, which then become life-threatening.

 

Furthermore, if the heart has another problem, the left ventricular heart obstruction can worsen cardiac problems.

 

There is no direct link between obstruction and risks, but the main problem with obstruction is that it causes regular symptoms.

 

How is LVOTO treated?

For the management of LVOTO, we use a number of drugs /medications, which must be used with caution. This is because although they have a positive effect on the obstruction, they also have some negative side effects.

 

This means that we need to find the correct combination and the right balance of drugs which will be beneficial for the patient.

 

In some cases, the medication doesn’t work for the patient and therefore we need to look for other options. We have a number of interventional options and a surgical operation (surgical myectomy), which is considered the gold standard of the management of obstruction because it corrects the thick wall of the heart, the abnormalities of the valve and everything else that contributes to obstruction within the left ventricle.

 

In the past we only offered the treatment to patients who were very symptomatic. However, given that the risks associated with the operation are becoming significantly reduced in large, experienced centres, there is a discussion that we should be offering this treatment to patients very earlier than what we used to.

 

 

 

If you are experiencing any cardiological issues and would like to book a consultation with Dr Pantazis, simply visit his Top Doctors profile today.

By Dr Antonis Pantazis
Cardiology

Dr Antonis Pantazis is a leading consultant cardiologist who has many years of experience working within the field of cardiomyopathies. He possesses a special interest in the clinical manifestation of the cardiomyopathies (heart muscle condions), their arrhythmogenic manifestation, the risk prevention and the genetic causes of cardiomyopathies.

Additionally, he has a major interest in the cardiac manifestation of neuromuscular conditions, as well as the interaction between sports and cardiac conditions. He also has great experience in pericardial diseases.
 
Dr Pantazis also has an interest in the cardiac imaging diagnostic modalities, and more particularly uses advanced echocardiography imaging in his practice in order to investigate complex heart conditions, including valve diseases and ischaemic heart disease.

Dr Pantazis sees patients who have suspected or confirmed diagnosis of heart muscle and/or pericardial conditions. He also sees patients who may have cardiac symptoms which have not yet been attributed to any pathology. He offers detailed diagnosis, personalised treatment and guides them through interventional management, when required. His practice also covers investigating the diagnosis of the inherited conditions in the family members with genetic and clinical tests.
 
Dr Pantazis has also been leading the Hospital’s programme for the medical (non-invasive) and invasive management of the left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Left ventricular outflow tract obstruction (LVOTO) is a complex dynamic pathology inside the heart which is responsible for significant symptoms such as breathlessness and chest pain on exertion, palpitations, light-headedness and fainting. Its management requires expertise and patient-specific approach. He runs dedicated clinics for arrhythmogenic cardiomyopathy (ARVC), and cardio-neuromuscular diseases.
 
Dr Pantazis started working as a consultant cardiologist in the cardiomyopathy service of the Heart Hospital, University College London Hospitals NHS Foundation Trust (UCLH) from 2007. He has been the leading cardiologist at UCLH's neuromuscular complex care centre (NMCCC) in The National Hospital for Neurology and Neurosurgery and the academic lead for echocardiography at the Institute for Cardiovascular Science, University College London (UCL).
 
He has been a consultant cardiologist at The Royal Brompton & Harefield NHS Foundation Trust since 2015 and the Trust's clinical lead for cardiomyopathy and inherited cardiovascular conditions. He is also the head of the echocardiography department at North Middlesex Hospital. He has held the position as Consultant Cardiologist at the Royal Brompton Hospital since 2016. 
 
Dr Pantazis is an educational and clinical supervisor to junior doctors. He is responsible for various educational activities in his scientific field, both nationally and internationally.
 
He continues to be involved in research related to phenotype/genotype manifestation of hypertrophic, dilated and arrhythmogenic cardiomyopathy and of left-ventricular non-compaction cardiomyopathy. He has special research interest in the mechanisms and treatment of LVOTO in hypertrophic cardiomyopathy, disease progression and risk in arrhythmogenic (ARVC) cardiomyopathy, the cardiac phenotype in Friedreich's ataxia and the cardiac expression of neuromuscular diseases,. His research has been funded by a number of international grants and his cardiomyopathy-related research outcomes have been published in various peer-reviewed journals.
 
He is also an invited speaker at many national and international meetings. Dr Pantazis contributed to cardiac recommendations on Friedreich's ataxia for Ataxia UK and is also an active supporter of charities, including Cardiomyopathy UK. He is current Chairman of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases and from this position organises and contributes to international publications and educational activities of high impact.

Additionally to the above services, Dr Pantazis offers second and expert opinions in complex cases on request.
 

View Profile

Overall assessment of their patients


  • Related procedures
  • Heart attack
    Arrhythmia
    Hypertension (high blood pressure)
    Pericarditis
    Heart failure
    Injury valves
    Heart murmur
    Echocardiogram
    Electrocardiogram
    Ambulatory electrocardiogram (Holter)
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.